Saturday 17 October 2026
Export ACON’s income statement to Excel — free account
Aclarion, Inc.
ACON Healthcare Health Information Services
Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024. In the quarter to June 2026, revenue grew 30.6%, EPS grew 59.3% and free cash flow fell 41.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.85
0.10
−5.13%
Follow ACON
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | — | — | 7 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(4.92) | (41.92) | (32.10) | — | — | — | — | — |
P/S ratio |
32.33 | 25.65 | 39.68 | 0.00 | 6,200,318.40 | 6,200,318.40 | 6,200,318.40 | — |
Altman Z″-Score (non-manufacturers) |
4.23 | (96.28) | (77.31) | (51.19) | (90.21) | (131.66) | (98.24) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(7.47) | — | — | — | — | — | — | — |
P/Operating CF |
(1.50) | (1.27) | (4.08) | 0.00 | (1,152,289.30) | (1,152,289.30) | (1,152,289.30) | — |
P/B ratio |
0.19 | 1.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
(123.47) | 20.91 | 29.29 | (20.46) | 6,200,321.64 | 6,200,321.64 | 6,200,321.64 | — |
EV/EBITDA |
1.37 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
1.30 | (0.18) | (0.61) | 0.25 | (147,755.19) | (147,755.19) | (147,755.19) | — |
EV/FCF |
1.27 | (0.17) | (0.59) | 0.24 | (138,507.57) | (138,507.57) | (138,507.57) | — |
Quick Ratio |
14.42 | 0.42 | 0.33 | 2.18 | 0.06 | 0.00 | 0.05 | — |
Current Ratio |
14.81 | 0.71 | 0.40 | 2.47 | 0.10 | 0.01 | 0.07 | — |
Net Debt/EBITDA |
1.76 | 0.10 | 0.24 | 0.27 | 0.16 | (0.05) | (0.11) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 19.11% | 37.61% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.03) | (0.32) | — |
Asset Turnover |
0.01 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | — |
Operating CF/Net income |
0.99 | 0.75 | 0.74 | 0.66 | 0.40 | 0.33 | 0.86 | — |
Capex/Depreciation |
(0.90) | (0.48) | (0.18) | (1.45) | (0.55) | (0.91) | 0.00 | — |
Interest Coverage |
— | (10.30) | (8.02) | (3.69) | (6.22) | (28.68) | (1,605.64) | — |
| (104.89%) | (5,826.19%) | (655.73%) | 141.13% | 59.81% | 124.90% | 0.00% | — | |
| (91.67%) | (307.75%) | (182.77%) | (311.57%) | (374.43%) | (403.12%) | (677.67%) | — | |
ROIC |
(554.92%) | (680.42%) | 0.00% | (467.71%) | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(62.50%) | 2,179.42% | 258.96% | (736.84%) | 86.64% | 66.49% | 169.15% | — |
Average Days of Receivables |
143.20 | 146.16 | 64.38 | 112.40 | 38.13 | 168.63 | 199.46 | — |
Research and Development Expense of Revenue |
1,365.65% | 1,944.86% | 1,158.22% | 1,768.21% | 1,306.63% | 2,160.37% | 6,234.94% | — |
Selling, General and Administrative Expense of Revenue |
7,959.58% | 10,033.48% | 5,308.09% | 7,431.62% | 3,575.95% | 2,890.55% | 8,107.81% | — |
Intangible Assets out of Total Assets |
0.09 | 0.61 | 0.48 | 0.42 | 0.61 | 0.90 | 0.81 | 0.00 |
Share Based Compensation of Revenue |
139.23% | 629.10% | 604.77% | 1,964.74% | 294.36% | 53.59% | 0.00% | — |
Graham Net Nets |
4.72 | (0.28) | (0.63) | 0.00 | 0.00 | 0.00 | 0.00 | — |
Graham Number |
0.00 | 0.00 | 114,650.23 | 0.00 | 41.74 | 0.00 | 0.00 | — |
Earnings Yield |
(369.78%) | (569.97%) | (267.88%) | (202.30%) | 0.00% | 0.00% | 0.00% | — |
Free Cash Flow Yield |
(301.29%) | (477.08%) | (125.69%) | 0.00% | 0.00% | 0.00% | 0.00% | — |
Revenue per Share |
0.14 | 50.78 | 754.00 | 0.00 | 0.07 | 0.01 | 0.06 | — |
Operating CF per Share |
(13.47) | (5,857.33) | (36,469.00) | 0.00 | (2.65) | (0.27) | (9.29) | — |
Capex per Share |
(0.38) | (357.67) | (1,195.00) | 0.00 | (0.11) | (0.03) | 0.00 | — |
Free Cash Flow per Share |
(13.85) | (6,215.00) | (37,664.00) | 0.00 | (2.76) | (0.29) | (9.29) | — |
Cash per Share |
22.63 | 515.22 | 10,311.00 | 0.00 | 0.50 | 0.00 | 0.29 | — |
Shareholders Equity per Share |
24.13 | 1,077.89 | (7,280.00) | 0.00 | (6.33) | (1.05) | (3.79) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
24.13 | 1,077.89 | (7,280.00) | 0.00 | (6.33) | (1.05) | (3.79) | — |
Free Cash Flow |
(7.37) | (5.59) | (3.77) | (5.16) | (2.50) | (1.97) | (4.17) | — |
Working Capital |
11.56 | (0.33) | (1.90) | 1.01 | (6.89) | (8.28) | (2.91) | — |
Capital Expenditures |
(0.20) | (0.32) | (0.12) | (0.21) | (0.10) | (0.18) | (0.27) | — |
Net Current Asset Value |
11.56 | (0.33) | (1.90) | 1.01 | (6.89) | (8.28) | (2.91) | — |
EV/EBIT |
1.33 | 0.00 | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
2.69 | 7.04 | 1.58 | 3.44 | 1.69 | 3.68 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
9.40 | 120.82 | 366.83 | 43.52 | 14.79 | 7.67 | 3.67 | — |
Cash ROIC |
(29.62%) | (390.12%) | (1,242.63%) | (139.05%) | 47.41% | 28.92% | 402.74% | — |
Accounts Receivable Turnover |
3.15 | 2.89 | 4.73 | 4.85 | 4.19 | 2.62 | 0.00 | — |
Accounts Payable Turnover |
0.16 | 0.13 | 0.12 | 0.09 | 0.06 | 0.08 | 0.00 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
1,764.08 | 2,290.84 | 3,666.88 | 2,583.51 | 5,619.00 | 6,325.20 | 1,004.75 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | — | — |
Average Payables |
0.43 | 0.65 | 0.61 | 0.76 | 1.11 | 0.82 | — | — |
Average Assets |
7.90 | 2.29 | 2.69 | 2.40 | 1.59 | 1.36 | 0.72 | — |
Average Common Equity |
6.90 | 0.12 | 0.75 | (5.30) | (9.96) | (4.39) | — | — |
Columns are period end dates